Pyridoxamine Petition Paints Better Option As Dietary Ingredient Than IND

ViGuard Health says in a petition that with two IND programs for studies of pyridoxamine's potential therapeutic use formally withdrawn, FDA should rescind its 2009 decision that it did not qualify as a dietary ingredient.

GoldKeyInPuzzle_1200x675

FDA might need a program to keep track of the players in a citizen petition asking the agency to reverse its decision that a common form of vitamin B6, pyridoxamine, is not a dietary ingredient and remove any uncertainty about its use in dietary supplements.

ViGuard Health Inc., of Raleigh, N.C., says that with two investigational new drug programs for studies of pyridoxamine's potential therapeutic...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Ingredients & Safety

More from HBW Insight